West Pharmaceutical Services Q3 2025 Earnings Report

West Pharmaceutical Services EPS Results

• Actual EPS: N/A
• Consensus EPS: $1.67
• Beat/Miss: N/A
• One Year Ago EPS: N/A

West Pharmaceutical Services Revenue Results

• Actual Revenue: N/A
• Expected Revenue: $788.42 million
• Beat/Miss: N/A
• YoY Revenue Growth: N/A

West Pharmaceutical Services Announcement Details

• Quarter: Q3 2025
• Date: 10/23/2025
• Time: Before Market Opens
• Conference Call Date: Thursday, October 23, 2025
• Conference Call Time: 9:00AM ET

West Pharmaceutical Services (NYSE:WST) is a global leader in the design and manufacturing of drug packaging and delivery solutions for the pharmaceutical and biotechnology industries. The company specializes in elastomeric and polymer components that ensure the integrity and safety of injectable medicines, including vial stoppers, syringe plungers, cartridge-based delivery systems and complete safety-engineered administration devices.

With a product portfolio that spans containment and delivery platforms, West supports both traditional small-molecule injectables and advanced biologics. Its offerings include prefillable syringe systems, custom-engineered polymer components and integrated safety systems designed to reduce needlestick injuries and enhance patient compliance. The company also provides design, testing and regulatory support to help customers accelerate development timelines and meet stringent global quality standards.

Founded in 1923 and headquartered in Exton, Pennsylvania, West has grown into a multinational enterprise serving more than 200 customers in over 50 countries. The company operates manufacturing facilities, R&D centers and technical service laboratories across North America, Europe and Asia-Pacific. This global footprint enables close collaboration with leading pharmaceutical and biotech firms at every stage of drug development and commercialization.

Under the leadership of President and Chief Executive Officer Eric P. Green, West continues to invest in innovation, quality assurance and sustainability initiatives. The company’s long-standing relationships with top global drug makers, combined with its emphasis on engineering excellence and regulatory compliance, have positioned West as a trusted partner in advancing injectable therapies worldwide.